These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2255063)

  • 21. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABO-incompatible bone marrow transplantation: prevention of hemolysis by alkaline hydration with mannitol diuresis in conjunction with red cell reduced buffy coat bone marrow.
    Slavc I; Urban C; Schwinger W; Hauer C; Vadon M
    Wien Klin Wochenschr; 1992; 104(4):93-6. PubMed ID: 1570714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABO-incompatible kidney transplantation of an 8-yr-old girl with donor/recipient-constellation A1B/B.
    Ahlenstiel T; Offner G; Strehlau J; Pape L; Froede K; Ehrich JH; Schwarz A; Heuft HG; Klempnauer J
    Xenotransplantation; 2006 Mar; 13(2):141-7. PubMed ID: 16623809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of techniques for dealing with major ABO-incompatible marrow transplants.
    Bensinger WI; Buckner CD; Clift RA; Williams BM; Banaji M; Thomas ED
    Transplant Proc; 1987 Dec; 19(6):4605-8. PubMed ID: 3321630
    [No Abstract]   [Full Text] [Related]  

  • 25. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Stussi G; Muntwyler J; Passweg JR; Seebach L; Schanz U; Gmür J; Gratwohl A; Seebach JD
    Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion-related problems following major ABO-incompatible bone marrow transplantation.
    Tasaki T; Satoh S; Gotoh K; Fujii K; Sasaki S; Takadate J; Tachibana M; Ono Y; Ishida Y
    Transfus Apher Sci; 2003 Apr; 28(2):155-61. PubMed ID: 12679120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult ABO-incompatible liver transplantation, using A and B donors.
    Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
    Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment with bolus methylprednisolone for pure red cell aplasia after ABO incompatible bone marrow transplantation in a patient with chronic myelocytic leukemia].
    Furuya H; Wakayama T; Tanaka J; Tsumori M; Hatazoe T; Ohguni S; Sato T; Ishikura H; Kato Y
    Rinsho Ketsueki; 1995 Nov; 36(11):1279-83. PubMed ID: 8691568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of ABH incompatible bone marrow: gravity sedimentation of donor marrow.
    Ho WG; Champlin RE; Feig SA; Gale RP
    Br J Haematol; 1984 May; 57(1):155-62. PubMed ID: 6372850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice.
    Tomita H; Fuchimoto Y; Mori T; Kato J; Uemura T; Handa M; Tazawa H; Ohdan H; Okamoto S; Kuroda T
    Clin Transplant; 2013; 27(6):E702-8. PubMed ID: 24125194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?
    Mehta J; Powles R; Sirohi B; Treleaven J; Kulkarni S; Saso R; Tait D; Singhal S
    Bone Marrow Transplant; 2002 May; 29(10):853-9. PubMed ID: 12058235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma glycosyltransferase activity after ABO-incompatible bone marrow transplantation and development of an inhibitor for glycosyltransferase activity.
    Matsue K; Yasue S; Matsuda T; Iwabuchi K; Ohtsuka M; Ueda M; Kondo K; Shiobara S; Mori T; Koizumi S
    Exp Hematol; 1989 Aug; 17(7):827-31. PubMed ID: 2502424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.
    Kalaycioglu M; Copelan E; Avalos B; Klein J; Goormastic M; Bolwell B
    Bone Marrow Transplant; 1995 Jan; 15(1):105-10. PubMed ID: 7742742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune haemolysis after renal transplantation secondary to ABO minor-mismatch between donor and recipient.
    Jayaranee S; Ramesh P; Nadesan V
    Singapore Med J; 2002 Aug; 43(8):421-2. PubMed ID: 12507029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
    Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
    Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the ABO incompatibility a risk factor in bone marrow transplantation?
    Rozman P; Kosir A; Bohinjec M
    Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohematologic problems arising from ABO incompatible bone marrow transplantation.
    Sniecinski IJ; Petz LD; Oien L; Blume KG
    Transplant Proc; 1987 Dec; 19(6):4609-11. PubMed ID: 3321631
    [No Abstract]   [Full Text] [Related]  

  • 38. Allogeneic bone marrow transplantation from a major ABO-incompatible donor. Infusion of hemopoietic stem cells isolated by Ficoll-Hypaque method.
    Harada M; Aoyagi N; Kondo K; Ishino C; Odaka K; Matsue K; Yoshida T; Hattori K
    Transplantation; 1983 Feb; 35(2):191-2. PubMed ID: 6131551
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes.
    Michelis FV; Branch DR; Scovell I; Bloch E; Pendergrast J; Lipton JH; Cserti-Gazdewich CM
    Transfusion; 2014 Mar; 54(3):681-90. PubMed ID: 23829192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation.
    Yazer MH; Triulzi DJ
    Curr Opin Hematol; 2007 Nov; 14(6):664-70. PubMed ID: 17898572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.